Tff Pharmaceuticals Stock Probability Of Bankruptcy
Tff Pharmaceuticals' odds of distress is above 80% at this time. It has very high probability of going through financial hardship in the upcoming years. Probability of distress prediction helps decision makers evaluate Tff Pharmaceuticals' chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the Tff balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Tff |
Tff Pharmaceuticals Company probability of distress Analysis
Tff Pharmaceuticals' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Tff Pharmaceuticals Probability Of Bankruptcy | Over 100% |
Most of Tff Pharmaceuticals' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tff Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Tff Pharmaceuticals probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Tff Pharmaceuticals odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Tff Pharmaceuticals financial health.
Please note, there is a significant difference between Tff Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tff Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tff Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Tff Pharmaceuticals has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the Pharmaceuticals sector and 82.35% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Tff Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tff Pharmaceuticals' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tff Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tff Pharmaceuticals by comparing valuation metrics of similar companies.Tff Pharmaceuticals is currently under evaluation in probability of bankruptcy category among its peers.
Tff Fundamentals
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 | ||||
| Operating Margin | (6.09) % | ||||
| Current Valuation | (2.27 M) | ||||
| Shares Outstanding | 4.44 M | ||||
| Shares Owned By Insiders | 3.31 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 157.16 K | ||||
| Price To Book | 0.09 X | ||||
| Price To Sales | 0.24 X | ||||
| Revenue | 733.87 K | ||||
| Gross Profit | (21.21 M) | ||||
| EBITDA | (20.74 M) | ||||
| Net Income | (21.24 M) | ||||
| Cash And Equivalents | 13.15 M | ||||
| Cash Per Share | 0.51 X | ||||
| Total Debt | 115.25 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (16.04 M) | ||||
| Short Ratio | 1.77 X | ||||
| Earnings Per Share | (5.50) X | ||||
| Target Price | 30.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 1.32 | ||||
| Market Capitalization | 288.8 K | ||||
| Total Asset | 12.03 M | ||||
| Retained Earnings | (118.33 M) | ||||
| Working Capital | 5.16 M | ||||
| Net Asset | 12.03 M |
Pair Trading with Tff Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tff Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tff Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Best Buy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Best Buy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Best Buy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Best Buy Co to buy it.
The correlation of Best Buy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Best Buy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Best Buy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Best Buy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |